← Return to [Study] Use of steroid inhalers increases risk of NTM in some patients

Discussion
sweethighland avatar

[Study] Use of steroid inhalers increases risk of NTM in some patients

MAC & Bronchiectasis | Last Active: May 15 3:28pm | Replies (13)
Comment receiving replies
Profile picture for happy2023 @happy2023

I use low dose Symbicort once daily as it is less of a burden than twice daily.
My pulmonologist recommends twice daily. How do I decide?
And what truly is the best option to safeguard lung health?

Jump to this post

Replies to "I use low dose Symbicort once daily as it is less of a burden than twice..."
Sue, Volunteer Mentor | @sueinmn | May 15 3:28pm

@happy2023 When you say "less of a burden" is it because you fear infection? My pulmonologist is adamant that improved lung function = less risk of infection.

Adequately treating asthma, shortness of breath, and inflammation (all of which Symbicort does) is important. Formoterol, the long-acting bronchodilator (LABA), stays in the system for about 12 hours, so twice a day is the recommended interval for optimum therapeutic effect. I am actually encouraged to use mine 3-4 times a day during my peak asthma/allergy times.

Budesonide, the corticosteroid portion of Symbicort, may stay in the body for more than 12 hours, enough has been eliminated to be less than a therapeutic level after 10-12 hours.

Have you had increased infections while using Symbicort?

VIEW AND REPLY